This Micron Technology Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Today

This Micron Technology Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Today

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Goldman Sachs analyst Toshiya Hari upgraded the rating for Teradyne, Inc. TER from Neutral to Buy, while increasing the price target from $118 to $161. Teradyne shares closed higher at $131.91 on Friday. See how other analysts view this stock.
  • Morgan Stanley analyst Joseph Moore upgraded Micron Technology, Inc. MU from Underweight to Equal-Weight and boosted the price target from $98 to $130. Micron shares slipped 2% to settle at $125.29 on Friday. See how other analysts view this stock.
  • Piper Sandler analyst Matt O’Brien upgraded the rating for Globus Medical, Inc. GMED from Neutral to Overweight, while raising the price target from $60 to $80. Globus Medical shares rose 0.7% to settle at $64.40 on Friday. See how other analysts view this stock. See how other analysts view this stock.
  • Jefferies analyst John Colantuoni upgraded MercadoLibre, Inc. MELI from Hold to Buy and announced a price target of $2,100. MercadoLibre shares closed at $1,749.17 on Friday. See how other analysts view this stock.
  • UBS analyst A.J. Rice upgraded the rating for Universal Health Services, Inc. UHS from Neutral to Buy, while raising the price target from $189 to $226. Universal Health shares settled at $177.70 on Friday. See how other analysts view this stock.

Check This Out: D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday

Latest Ratings for MU

Date Firm Action From To
Feb 2022 Wedbush Upgrades Neutral Outperform
Jan 2022 Goldman Sachs Maintains Buy
Jan 2022 New Street Research Initiates Coverage On Buy

View More Analyst Ratings for MU

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Related Articles